SOLICITATION NOTICE
70 -- Genomic Information Management System Licenses
- Notice Date
- 7/1/2015
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 511210
— Software Publishers
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- FDA-RFQ-15-1146899
- Archive Date
- 7/21/2015
- Point of Contact
- Jacob A. O'Hatnick, Phone: 3018276758
- E-Mail Address
-
jacob.ohatnick@fda.hhs.gov
(jacob.ohatnick@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-82-1. This is total a small business set-aside with NAICS Code 511210 Size Standard $38.5 million. The provision at 52.212-1, Instructions to Offerors-Commercial applies to this acquisition. Evaluation of quotes is Lowest Priced Technically Acceptable. Offerors are advised to to include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items with offers. FAR Clauses 52.212-4, Contract Terms and Conditions-Commercial Items, and 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Items apply to this acquisition. Offers are due to the point of contact via email NLT July 6, 2015 at 9 AM ET. Genomic Information Management System Site Licenses for 36 Users with the following specifications: •The GIMS software provided must be capable of interfacing with at least the following scientific instruments: Illumina's MiSeq and HiSeq Genomic Sequencers, Pacific Biosciences' PacBio Genomic Sequencers, Life Technology's Ion Torrent Sequencers. •The GIMS must be able to collect data from various instruments used in the DNA preparation and QC steps preceding the sequencing instruments such as Agilent BioAnalyzers and TapeStations and liquid handlings systems such as the Sciclone. •The GIMS must be able to capture instrument-related events and trigger operations such as initiating preliminary data analysis when a sequencing run is finished •The GIMS must provide sufficient configurability and flexibility for the DM users to add data fields, build processes and workflows and be able to be reconfigured at any time. •Workflow versions must be given unique IDs and must be able to be archived when they are replaced with an updated version. The workflow version must also be able to be captured and retained as a component of the metadata for each sequencing run. •Users must be able to stop or re-run a workflow at any time. •The GIMS must be able to track which instrument was used for a particular workflow step as well as other instrument-specific information such as: (a.)user authentication (b.)calibration history (c.)maintenance schedules and events. In addition to data interface. •Minimum Required Licenses •The GIMS must be able to manage documents related to audit tracking, such as alert emails, multiple versions of SOPs, and MSDS documents. •The GIMS must also be capable of tracking sample chain of custody. This must show control, transfer, analysis and disposition of samples/results with chronological documentation. •Barcoding - The GIMS must support or include barcoding capabilities using COTS barcode scanners and barcode printers. The GIMS must have the capacity to barcode all physical components of the workflows such as samples, tubes, containers, freezers, and reagents. •Batching Data - The GIMS must be able to handle all data in batch form. Any fillable metadata fields must be able to be imported/appended via batch operation. •File Management - The GIMS must be able to support management of large data files (20 GB to 500 TB) such as sequence data. Sequence data will not be stored within the GIMS system, but the GIMS system must be able to provide a link to the storage location of these large data files as well as saving and managing the links referencing these data files. •Text Search - The GIMS must have full text search across all fields of the database. •Attachments - The GIMS must be capable of document attachment. The GIMS must support all common types of file attachments, such as MS Excel-compatible formats, CSV, tab-delimited text, MS Access Database files, PDF. Attached files must be able to be linked to an individual sample, workflow step, or sequence result. •Data Exchange - The GIMS must be capable of electronic data exchange with analytical platforms or packages such as CLC Bio Genomics Workbench/Server and Applied-Math's BioNumerics Software. •The GIMS must be able to take defined actions based upon specified events. Event-driven actions should include things like alerts when isolates are ready for the next step in a particular workflow, notifications when samples are finished being sequenced and are ready for post-run processing. •An interface for customizing the capture and response of these events must be provided. •The GIMS must be capable of inventory management for reagent and supply rotation and re-ordering. All laboratory supplies and reagents used in the DM's workflows must be able to be tracked in the GIMS system using supply lot codes and expiration dates. •The GIMS must be able to identify storage locations for these supplies and locations. •The GIMS must be able to track reagent supply levels and have the ability to have alerts set for when supply levels fall below user-defined thresholds. •Sample IDs - The GIMS must allow unique sample IDs to be auto-generated for new incoming samples using a pattern and format determined by the DM. •Report Generation - The GIMS must be able to generate custom scheduled and ad-hoc reports to be scheduled by the end user. Reports may consist of daily/weekly/monthly/annual workflow throughput summaries. Reports may also take the form of QA reports for individual or batches of sequencing runs. Reports should be able to be emailed to necessary parties within DM when they are generated. Report format should be in Word and PDF. •.Samples shall be prioritized in the queue according to their priority level. DM Managers must be able to change the priority level of a sample as needed. •Workflows shall be designed to allow a sample to be returned back to a DM predetermined step in each workflow for re-run if the sample has failed for any reason.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-RFQ-15-1146899/listing.html)
- Place of Performance
- Address: FDA/CFSAN, FDA College Park Campus, 5100 Paint Branch Pkwy, College Park, Maryland, 20740, United States
- Zip Code: 20740
- Zip Code: 20740
- Record
- SN03783736-W 20150703/150702000506-a239a096402e5ccd8bf16421f31ead75 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |